NCT04977388View on ClinicalTrials.gov

NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

October 30, 2023

Study Completion Date

June 29, 2024

Conditions
Menkes DiseaseOccipital Horn Syndrome
Interventions
DRUG

Droxidopa

Subjects will self-administer capsules of Droxidopa by mouth twice daily for six weeks.

OTHER

Placebo

Subjects will self-administer capsules of placebo by mouth twice daily for six weeks.

Trial Locations (1)

10032

Vagelos College of Physicians and Surgeons, Columbia University, New York

All Listed Sponsors
lead

Stephen G. Kaler, MD

OTHER